Jagadeesha's brain, the first juvenile Huntington's Disease donation in India, offers hope for vital neurodegenerative research at NIMHANS.

UniQure shares soared on positive AMT-130 Huntington's disease data, but plunged after the FDA reversed its stance on ...

Researchers and families unite to address Huntington's disease, exploring innovative therapies and fostering connections at ...

Eight years later, suffering from frequent falls, involuntary movements, and the inability to eat, Sarah’s grandmother passed ...

A retired Toledo firefighter battling Huntington’s disease was surprised Monday by current and former colleagues at the Toledo Firefighters’ Museum.

"Though mosquito season is now over, this case serves as a reminder that mosquitoes carrying disease were still biting after ...

Involuntary movements caused by tardive dyskinesia (TD), a movement disorder induced by dopamine-receptor antagonists like ...

The results of the ALLEGORY trial of Gazyva (obinutuzumab) suggest that the anti-CD20 antibody could have broad utility in ...

Early detection of Alzheimer's disease has come a step closer thanks to a new measurement method developed by chemists at ...

A study found 26 DNA regions tied to fibromyalgia, showing the disorder originates in the brain’s pain circuits, not in muscles.

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its ...